Significance of Neutrophil to Lymphocyte Ratio (NLR) and Platelet Lymphocyte Ratio (PLR) in Diabetic Foot Ulcer and Potential New Therapeutic Targets

Diabetic foot ulcer (DFU) is a well-known complication of diabetes and a significant burden on the national health systems. The neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio are inexpensive and easily accessible biomarkers that have proved to be useful in several inflammatory, infectious and cardiovascular diseases. We carried out a comprehensive review examining the association of NLR and PLR with the onset and progression of DFU. PLR and NLR were significantly increased in patients with DFU, compared with a control group of T2DM patients without DFU, and correlate well with DFU severity, evaluated by Wagner and IWGDF grading scales. In patients with diabetic foot infections (DFI), elevated NLR and PLR were correlated with osteomyelitis, increased risk of amputation, and septic complications. The significance of the elevated value of these biomarkers in DFU is related to chronic hyperglycemia and low-grade systemic inflammation, atherosclerotic and vascular complications, and also the associated septic factor. Serial, dynamic follow-up can provide useful information in planning and monitoring DFU treatment, as well as in risk stratification of these vulnerable patients. Further randomized studies are needed to set the cut-off values with clinical significance.

[1]  J. Aragón-Sánchez,et al.  Clinical, microbiological and inflammatory markers of severe diabetic foot infections , 2021, Diabetic medicine : a journal of the British Diabetic Association.

[2]  T. Gregório,et al.  Pre-operative Neutrophil to Lymphocyte Ratio is Associated With 30 Day Death or Amputation After Revascularisation for Acute Limb Ischaemia. , 2021, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[3]  T. Wittlinger,et al.  Neutrophil-to-Lymphocyte Ratio as a Cardiovascular Risk Marker May Be Less Efficient in Women Than in Men , 2021, Biomolecules.

[4]  C. Xing,et al.  Association of platelet-to-lymphocyte ratio with kidney clinicopathologic features and renal outcomes in patients with diabetic kidney disease. , 2021, International immunopharmacology.

[5]  M. Mussbacher,et al.  Platelet-leukocyte interplay during vascular disease. , 2020, Atherosclerosis.

[6]  Yue Yin,et al.  Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history , 2020, Diabetology & Metabolic Syndrome.

[7]  M. Bharathi,et al.  Study of Neutrophil-Lymphocyte ratio (NLR) in diabetes mellitus , 2020, Tropical Journal of Pathology and Microbiology.

[8]  Yingli Lu,et al.  Associations between the Neutrophil-to-Lymphocyte Ratio and Diabetic Complications in Adults with Diabetes: A Cross-Sectional Study , 2020, Journal of diabetes research.

[9]  D. Armstrong,et al.  Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer , 2020, Journal of Foot and Ankle Research.

[10]  D. Armstrong,et al.  Global Disability Burdens of Diabetes-Related Lower-Extremity Complications in 1990 and 2016 , 2020, Diabetes Care.

[11]  T. Sabuncu,et al.  The role of the platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in the prediction of length and cost of hospital stay in patients with infected diabetic foot ulcers: A retrospective comparative study. , 2020, Acta orthopaedica et traumatologica turcica.

[12]  K. Alemdaroğlu,et al.  Monitoring the Prognosis of Diabetic Foot Ulcers: Predictive Value of Neutrophil-to-Lymphocyte Ratio and Red Blood Cell Distribution Width , 2020, The international journal of lower extremity wounds.

[13]  Yunus Gürbüz,et al.  Predicting diabetic foot ulcer infection using the neutrophil-to-lymphocyte ratio: a prospective study. , 2019, Journal of wound care.

[14]  K. Egan,et al.  Sociodemographic and lifestyle factors associated with the neutrophil-to-lymphocyte ratio. , 2019, Annals of epidemiology.

[15]  Xuerui Tan,et al.  Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in Chinese Han population from Chaoshan region in South China , 2019, BMC Cardiovascular Disorders.

[16]  J Zhang,et al.  The relationship between mean platelet volume and diabetic retinopathy: a systematic review and meta-analysis , 2019, Diabetology & Metabolic Syndrome.

[17]  M. Kocak,et al.  Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus , 2019, African health sciences.

[18]  G. Kitas,et al.  The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases , 2019, Annals of laboratory medicine.

[19]  J. Baillie,et al.  The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: A systematic review and meta-analysis , 2019, Journal of Infection.

[20]  Jinbao Liu,et al.  Hydrogen sulfide primes diabetic wound to close through inhibition of NETosis , 2019, Molecular and Cellular Endocrinology.

[21]  T. Demirdal,et al.  The significance of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and lymphocyte-monocyte ratio in predicting peripheral arterial disease, peripheral neuropathy, osteomyelitis and amputation in diabetic foot infection. , 2018, Diabetes research and clinical practice.

[22]  M. Kaur,et al.  Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies , 2018, Cardiovascular Diabetology.

[23]  B. Stricker,et al.  Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: a population-based prospective cohort study , 2018, Scientific Reports.

[24]  M. Bortolozzi,et al.  The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo , 2018, Acta Diabetologica.

[25]  Leila Yazdanpanah,et al.  Incidence and Risk Factors of Diabetic Foot Ulcer: A Population-Based Diabetic Foot Cohort (ADFC Study)—Two-Year Follow-Up Study , 2018, International journal of endocrinology.

[26]  A. Basit,et al.  Neutrophil-to-lymphocyte ratio and microvascular complications in subjects with type 2 diabetes: Pakistan’s perspective , 2018, Turkish journal of medical sciences.

[27]  M. Hussain,et al.  Neutrophil lymphocyte ratio (NLR): A well assessment tool of glycemic control in type 2 diabetic patients , 2017, Pakistan journal of medical sciences.

[28]  Nicholas A. Giovinco,et al.  Does Everything That’s Counted Count? Value of Inflammatory Markers for Following Therapy and Predicting Outcome in Diabetic Foot Infection , 2017, The international journal of lower extremity wounds.

[29]  T. Dülgeroğlu,et al.  Comparison of the Neutrophil/Lymphocyte Ratio and C-Reactive Protein Levels in Patients With Amputation for Diabetic Foot Ulcers , 2017, The international journal of lower extremity wounds.

[30]  O. Yapıcı,et al.  Can Ratio of Neutrophil-to-Lymphocyte Count and Erythrocyte Sedimentation Rate in Diabetic Foot Infecti on Predict Osteomyelitis and/or Amputation? , 2017, Hematology reports.

[31]  G. Moneta,et al.  Predictive value of neutrophil‐to‐lymphocyte ratio in diabetic wound healing , 2017, Journal of vascular surgery.

[32]  P. Forget,et al.  What is the normal value of the neutrophil-to-lymphocyte ratio? , 2017, BMC Research Notes.

[33]  V. Mohan,et al.  Association of neutrophil-lymphocyte ratio with metabolic syndrome and its components in Asian Indians (CURES-143). , 2016, Journal of diabetes and its complications.

[34]  Gongcheng Wang,et al.  High neutrophil‐to‐lymphocyte ratio is associated with increased carotid artery intima‐media thickness in type 2 diabetes , 2016, Journal of diabetes investigation.

[35]  A. Chawla,et al.  Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum? , 2016, Indian journal of endocrinology and metabolism.

[36]  F. Coşkun,et al.  Factors Affecting Mortality After Major Nontraumatic Lower Extremity Amputation , 2016, The international journal of lower extremity wounds.

[37]  T. Cha,et al.  The Combined Impact of Neutrophil-to-Lymphocyte Ratio and Type 2 Diabetic Mellitus on Significant Coronary Artery Disease and Carotid Artery Atherosclerosis , 2016, Journal of cardiovascular ultrasound.

[38]  L. Garcia,et al.  Neutrophil lymphocyte ratio in peripheral vascular disease: a review , 2016, Expert review of cardiovascular therapy.

[39]  O. Kweon,et al.  Neutropenia and neutrophil‐to‐lymphocyte ratio in a healthy Korean population: race and sex should be considered , 2016, International journal of laboratory hematology.

[40]  O. Ozeke,et al.  Platelet to lymphocyte ratio as a novel indicator of inflammation is correlated with the severity of metabolic syndrome: A single center large-scale study , 2016, Platelets.

[41]  F. Mammano,et al.  NETosis Delays Diabetic Wound Healing in Mice and Humans , 2016, Diabetes.

[42]  H. Suryapranata,et al.  Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease. , 2015, Diabetes & metabolism.

[43]  L. Venkatraghavan,et al.  Neutrophil–lymphocyte ratio as predictor of mortality and morbidity in cardiovascular surgery: a systematic review , 2015, ANZ journal of surgery.

[44]  A. Avogaro,et al.  NETosis is induced by high glucose and associated with type 2 diabetes , 2015, Acta Diabetologica.

[45]  Siyuan Yu,et al.  Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients , 2015, BMC Endocrine Disorders.

[46]  E. Taioli,et al.  Average Values and Racial Differences of Neutrophil Lymphocyte Ratio among a Nationally Representative Sample of United States Subjects , 2014, PloS one.

[47]  B. Zinman,et al.  White blood cell subtypes, insulin resistance and β‐cell dysfunction in high‐risk individuals – the PROMISE cohort , 2014, Clinical endocrinology.

[48]  Q. Wang,et al.  Neutrophils sense microbial size and selectively release neutrophil extracellular traps in response to large pathogens , 2014, Nature Immunology.

[49]  S. Legrand-Poels,et al.  Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. , 2014, Diabetes research and clinical practice.

[50]  H. Kaya,et al.  The association between platelet/lymphocyte ratio and coronary artery disease severity , 2014, Anatolian journal of cardiology.

[51]  E. Yengil,et al.  Investigation of neutrophil lymphocyte ratio and blood glucose regulation in patients with type 2 diabetes mellitus , 2014, The Journal of international medical research.

[52]  C. Kahraman,et al.  Neutrophil-to-lymphocyte ratio in diabetes mellitus patients with and without diabetic foot ulcer , 2014 .

[53]  I. Tanboğa,et al.  Correlation of Neutrophil to Lymphocyte Ratio With the Presence and Severity of Metabolic Syndrome , 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[54]  D. Bailey,et al.  Neutrophil to Lymphocyte Ratio Predicts Perioperative Mortality Following Open Elective Repair of Abdominal Aortic Aneurysms , 2014, Vascular and endovascular surgery.

[55]  A. Gerger,et al.  Platelet-to-Lymphocyte Ratio: A Novel Marker for Critical Limb Ischemia in Peripheral Arterial Occlusive Disease Patients , 2013, PloS one.

[56]  T. Costantino,et al.  Neutrophil to lymphocyte ratio and cardiovascular diseases: a review , 2013, Expert review of cardiovascular therapy.

[57]  R. Cubbon,et al.  Cell‐specific insulin resistance: implications for atherosclerosis , 2012, Diabetes/metabolism research and reviews.

[58]  R. Agha,et al.  Neutrophil-Lymphocyte Ratio Predicts Medium-Term Survival Following Elective Major Vascular Surgery: A Cross-Sectional Study , 2011, Vascular and endovascular surgery.

[59]  J. Spark,et al.  An elevated neutrophil-lymphocyte ratio independently predicts mortality in chronic critical limb ischemia. , 2010, Journal of vascular surgery.

[60]  D. Schneider.  Factors Contributing to Increased Platelet Reactivity in People With Diabetes , 2009, Diabetes Care.

[61]  J. Plutzky,et al.  The pathologic continuum of diabetic vascular disease. , 2009, Journal of the American College of Cardiology.

[62]  L. Jonasson,et al.  Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease. , 2005, The American journal of cardiology.

[63]  M. Káplár,et al.  The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy , 2001, Platelets.

[64]  Y. Maehara,et al.  Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. , 2013, Journal of hepatology.

[65]  V. Mohan,et al.  Oxidative DNA damage and augmentation of poly(ADP-ribose) polymerase/nuclear factor-kappa B signaling in patients with type 2 diabetes and microangiopathy. , 2007, The international journal of biochemistry & cell biology.

[66]  J. Chan,et al.  White blood cell count is associated with macro- and microvascular complications in chinese patients with type 2 diabetes. , 2004, Diabetes care.